UniPharma

topics

Unlicensed Medicines

Unlicensed Medicines is tracked by UniPharma when it has a clear effect on sourcing, regulation, access, or commercial execution for pharma teams.

Related insights

Latest articles on Unlicensed Medicines

April 23, 2026

MHRA enforcement surge puts sharper scrutiny on illegal and unlicensed medicines supply

MHRA seized almost 20 million doses of illegally traded medicines in 2025, raising the stakes for UK sourcing controls, online monitoring, and supply-chain compliance.

Read insight
April 23, 2026

UK chemotherapy shortage drives urgent orders for unlicensed cisplatin and carboplatin imports

A UK Tier 3 shortage alert for cisplatin and carboplatin is pushing trusts to source unlicensed imports and tighten aseptic and QA controls.

Read insight

Contact us

Need support with access, sourcing or regulated supply?

Bring us the access challenge, the shortage pressure or the regulated logistics brief. We will turn it into a clean operating plan.

Contact us View services